Aura Biosciences Statistics
Total Valuation
AURA has a market cap or net worth of $720.19 million. The enterprise value is $439.13 million.
Important Dates
The last earnings date was Monday, November 9, 2026, before market open.
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AURA has 104.07 million shares outstanding. The number of shares has increased by 52.09% in one year.
| Current Share Class | 104.07M |
| Shares Outstanding | 104.07M |
| Shares Change (YoY) | +52.09% |
| Shares Change (QoQ) | +17.09% |
| Owned by Insiders (%) | 1.22% |
| Owned by Institutions (%) | 73.22% |
| Float | 74.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.52 |
| P/TBV Ratio | 2.49 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 14.21, with a Debt / Equity ratio of 0.06.
| Current Ratio | 14.21 |
| Quick Ratio | 14.02 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -61.67% and return on invested capital (ROIC) is -37.98%.
| Return on Equity (ROE) | -61.67% |
| Return on Assets (ROA) | -35.48% |
| Return on Invested Capital (ROIC) | -37.98% |
| Return on Capital Employed (ROCE) | -48.37% |
| Weighted Average Cost of Capital (WACC) | 6.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.21M |
| Employee Count | 113 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, AURA has paid $92,000 in taxes.
| Income Tax | 92,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.96% in the last 52 weeks. The beta is 0.44, so AURA's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +27.96% |
| 50-Day Moving Average | 6.53 |
| 200-Day Moving Average | 6.83 |
| Relative Strength Index (RSI) | 52.05 |
| Average Volume (20 Days) | 720,435 |
Short Selling Information
The latest short interest is 10.46 million, so 10.05% of the outstanding shares have been sold short.
| Short Interest | 10.46M |
| Short Previous Month | 10.89M |
| Short % of Shares Out | 10.05% |
| Short % of Float | 14.02% |
| Short Ratio (days to cover) | 11.70 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -145.23M |
| Pretax Income | -136.86M |
| Net Income | -136.95M |
| EBITDA | -144.18M |
| EBIT | -145.23M |
| Earnings Per Share (EPS) | -$1.61 |
Full Income Statement Balance Sheet
The company has $297.23 million in cash and $16.17 million in debt, with a net cash position of $281.06 million or $2.70 per share.
| Cash & Cash Equivalents | 297.23M |
| Total Debt | 16.17M |
| Net Cash | 281.06M |
| Net Cash Per Share | $2.70 |
| Equity (Book Value) | 287.43M |
| Book Value Per Share | 2.77 |
| Working Capital | 281.76M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$109.30 million and capital expenditures -$379,000, giving a free cash flow of -$109.68 million.
| Operating Cash Flow | -109.30M |
| Capital Expenditures | -379,000 |
| Depreciation & Amortization | 1.06M |
| Net Borrowing | n/a |
| Free Cash Flow | -109.68M |
| FCF Per Share | -$1.05 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AURA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -52.09% |
| Shareholder Yield | -52.09% |
| Earnings Yield | -23.22% |
| FCF Yield | -15.34% |
Analyst Forecast
The average price target for AURA is $16.60, which is 139.88% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.60 |
| Price Target Difference | 139.88% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |